Literature DB >> 6476312

Serum morphine levels. A comparison between continuous subcutaneous infusion and continuous intravenous infusion in postoperative patients.

C S Waldmann, J R Eason, E Rambohul, G C Hanson.   

Abstract

A study was undertaken to compare continuous subcutaneous infusions of morphine with continuous intravenous infusions in patients whose lungs were mechanically ventilated for 24 hours postoperatively. Serum morphine levels were measured after the end of surgery and at 6, 12, 18 and 24 hours in nine patients receiving continuous subcutaneous morphine and in four patients receiving continuous intravenous morphine given at the same rate. At 6, 12, 18 and 24 hours the means of serum morphine levels in the intravenous group were 20 ng/ml, 17.75 ng/ml, 18.5 ng/ml and 18 ng/ml, respectively, the corresponding figures in the subcutaneous group being 23.2 ng/ml, 20 ng/ml, 20.7 ng/ml and 20 ng/ml. For the intravenous route the mean dose of supplementary analgesia was 14 mg of phenoperidine in the first 24 postoperative hours, whereas for the subcutaneous route the mean dose was 11.66 mg. The differences in the serum morphine levels and in the requirements of phenoperidine were not statistically significant. We conclude that a continuous subcutaneous infusion of morphine is a simple and effective means of achieving postoperative analgesia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6476312     DOI: 10.1111/j.1365-2044.1984.tb06520.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  10 in total

Review 1.  Assisted ventilation. 3. General care of the ventilated patient in the intensive care unit.

Authors:  M R Hamilton-Farrell; G C Hanson
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

2.  Association of an Opioid Standard of Practice Intervention With Intravenous Opioid Exposure in Hospitalized Patients.

Authors:  Adam L Ackerman; Patrick G O'Connor; Deirdre L Doyle; Sheyla M Marranca; Carolyn L Haight; Christine E Day; Robert L Fogerty
Journal:  JAMA Intern Med       Date:  2018-06-01       Impact factor: 21.873

3.  Syringe driver in terminal care.

Authors:  S B Dover
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-28

4.  Continuous subcutaneous pethidine for routine postoperative analgesia.

Authors:  H T Davenport; D Al-Khudairi; P N Cox; B M Wright
Journal:  Ann R Coll Surg Engl       Date:  1985-11       Impact factor: 1.891

5.  The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.

Authors:  R Stuart-Harris; S P Joel; P McDonald; D Currow; M L Slevin
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

Review 6.  Opioid analgesics: comparative features and prescribing guidelines.

Authors:  N I Cherny
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

7.  Pain management after lumbar spinal fusion surgery using continuous subcutaneous infusion of buprenorphine.

Authors:  Tomoyuki Kawamata; Yasumitsu Sato; Yukitoshi Niiyama; Keiichi Omote; Akiyoshi Namiki
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

8.  [Patient-controlled analgesia with subcutaneous opoids for out-patients with severe tumour pain.].

Authors:  H Goeke; M Herbst
Journal:  Schmerz       Date:  1993-03       Impact factor: 1.107

9.  Accidental subcutaneous remifentanil infusion as a cause of delayed awakening after craniotomy.

Authors:  Alexander Wolfson; Cephas Swamidoss
Journal:  Case Rep Anesthesiol       Date:  2011-11-03

10.  A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.

Authors:  Astrid W Oosten; João A Abrantes; Siv Jönsson; Maja Matic; Ron H N van Schaik; Peter de Bruijn; Carin C D van der Rijt; Ron H J Mathijssen
Journal:  Clin Pharmacokinet       Date:  2017-07       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.